Literature DB >> 18541090

CD5-positive acute lymphoblastic leukemia.

Dawood Ahmed1, Tahir Aziz Ahmed, Suhaib Ahmed, Hamid Nawaz Tipu, Muhammad Amin Wiqar.   

Abstract

CD5-positive B-ALL is a rare variant of Acute Lymphoblastic Leukemia (ALL). In literature, only three cases have been reported so far. This fourth case report describes a young lady who was diagnosed as ALL (L-2) on bone marrow examination and was found to be CD5 positive B-cell acute lymphoblastic leukemia on immunophenotyping. Cytogenetic analysis revealed translocation t(9:22).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18541090     DOI： 05.2008/JCPSP.310311

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN： 1022-386X            Impact factor:   0.711


  5 in total

1.  CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature.

Authors:  Sreejesh Sreedharanunni; Narender Kumar; Alka Khadwal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-04       Impact factor: 0.900

2.  Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report.

Authors:  Deepti Mutreja; Hara Prasad Pati; Divya Bansal; Rahul Kumar Sharma; Sonal Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2014-02-18       Impact factor: 0.900

3.  Surface Plasmon Resonance Immunosensor with Antibody-Functionalized Magnetoplasmonic Nanoparticles for Ultrasensitive Quantification of the CD5 Biomarker.

Authors:  Asta Kausaite-Minkstimiene; Anton Popov; Almira Ramanaviciene
Journal:  ACS Appl Mater Interfaces       Date:  2022-05-02       Impact factor: 10.383

4.  MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.

Authors:  Ja-Young Seo; Soo Hyun Lee; Hee-Jin Kim; Keon Hee Yoo; Hong Hoe Koo; Yong Gon Cho; Sam Im Choi; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

5.  Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Hematol Transfus Cell Ther       Date:  2020-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.